RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
1-Year Return
25.98%
This Quarter Return
+17.9%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.07B
AUM Growth
+$214M
(+25%)
Cap. Flow
+$126M
Cap. Flow
% of AUM
11.81%
Top 10 Holdings %
Top 10 Hldgs %
29.29%
Holding
121
New
28
Increased
49
Reduced
15
Closed
16
Top Buys
| 1 |
Pfizer
PFE
|
$26.4M |
| 2 |
Bausch Health
BHC
|
$18.2M |
| 3 |
Travere Therapeutics
TVTX
|
$16.8M |
| 4 |
Eli Lilly
LLY
|
$16.7M |
| 5 |
RDUS
Radius Health, Inc.
RDUS
|
$16.5M |
Top Sells
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$30.2M |
| 2 |
Merck
MRK
|
$25.6M |
| 3 |
STJ
St Jude Medical
STJ
|
$21.8M |
| 4 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$18.6M |
| 5 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$10.3M |
Sector Composition
| 1 | Healthcare | 75.22% |
| 2 | Financials | 1.56% |
| 3 | Industrials | 0.97% |
| 4 | Technology | 0.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JUNO
51
DELISTED
Juno Therapeutics, Inc.
JUNO
| $7.43M | 0.69% |
122,426
-22,000
| -15% | -$1.33M |
|
|
RLYP
52
DELISTED
RELYPSA INC COM
RLYP
| $7.39M | 0.69% |
205,000
+17,000
| +9% | +$613K |
|
53
DaVita
DVA
$9.81B
| $7.32M | 0.68% |
+90,000
| New | +$7.32M |
|
|
ADXS
54
DELISTED
Advaxis, Inc.
ADXS
| $7.08M | 0.66% |
32,667
+17,667
| +118% | +$3.83M |
|
|
ZSPH
55
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $6.65M | 0.62% |
158,000
+51,000
| +48% | +$2.15M |
|
|
WX
56
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $6.52M | 0.61% |
168,000
+60,500
| +56% | +$2.35M |
|
57
Theravance Biopharma
TBPH
$715M
| $6.49M | 0.61% |
374,000
+84,000
| +29% | +$1.46M |
|
|
GWPH
58
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $6.38M | 0.6% |
70,000
+42,000
| +150% | +$3.83M |
|
|
CNXR
59
DELISTED
Connecture, Inc.
CNXR
| $6.21M | 0.58% |
600,000
+45,775
| +8% | +$474K |
|
60
Steris
STE
$24.1B
| $6.18M | 0.58% |
88,000
+7,000
| +9% | +$492K |
|
61
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $6.09M | 0.57% |
199,051
-41,000
| -17% | -$1.25M |
|
62
Novavax
NVAX
$1.26B
| $6.04M | 0.56% |
36,500
+4,750
| +15% | +$786K |
|
63
Tandem Diabetes Care
TNDM
$844M
| $6.01M | 0.56% |
47,580
+12,580
| +36% | +$1.59M |
|
|
ACHN
64
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $5.92M | 0.55% |
600,000
+235,000
| +64% | +$2.32M |
|
|
KYTH
65
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $5.77M | 0.54% |
+115,000
| New | +$5.77M |
|
|
EPZM
66
DELISTED
Epizyme, Inc
EPZM
| $5.76M | 0.54% |
306,500
+125,000
| +69% | +$2.35M |
|
67
Puma Biotechnology
PBYI
$256M
| $5.73M | 0.54% |
24,250
+1,000
| +4% | +$236K |
|
68
Ultragenyx Pharmaceutical
RARE
$3.07B
| $5.71M | 0.53% |
92,000
+21,000
| +30% | +$1.3M |
|
|
WCG
69
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.49M | 0.51% |
60,000
| – | – |
|
|
CORV
70
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $5.23M | 0.49% |
+565,000
| New | +$5.23M |
|
|
ACT.PRA
71
DELISTED
ACTAVIS PLC PFD CONV SER A (IRL)
ACT.PRA
| $5.15M | 0.48% |
+5,000
| New | +$5.15M |
|
72
Dare Bioscience
DARE
$28.6M
| $4.87M | 0.46% |
4,500
-83
| -2% | -$89.7K |
|
73
FibroGen
FGEN
$46.1M
| $4.75M | 0.44% |
6,052
| – | – |
|
|
AERI
74
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.58M | 0.43% |
146,000
+6,000
| +4% | +$188K |
|
75
Regeneron Pharmaceuticals
REGN
$60.4B
| $4.52M | 0.42% |
10,000
+1,000
| +11% | +$452K |
|